Shock Syndromes II
Sihler KC, Napolitano LM. Complications of massive
transfusion. Chest. 2010;137(1):209-220. https://doi.
org/10.1378/chest.09-0252
Sims CA, Holena D, Kim P, et al. Effect of low-dose
supplementation of arginine vasopressin on need for
blood product transfusions in patients with trauma and
Surg. 2019;154(11):994-1003. https://doi.org/10.1001/
jamasurg.2019.2884
Spahn DR, Bouillon B, Cerny V, et al. The European
guideline on management of major bleeding and coag-
2019;23(1):98. https://doi.org/10.1186/s13054-019-2347-3
Sperry JL, Guyette FX, Brown JB, et al. Prehospital
plasma during air medical transport in trauma
patients at risk for hemorrhagic shock. N Engl J
Med.
2018;379(4):315-326.
https://doi.org/10.1056/
nejmoa1802345
Tomaselli GF, Mahaffey KW, Cuker A, et al. 2020 ACC
expert consensus decision pathway on management of
bleeding in patients on oral anticoagulants: a report of the
American College of Cardiology Solution Set Oversight
Committee. J Am Coll Cardiol. 2020;76(5):594-622.
https://doi.org/10.1016/j.jacc.2020.04.053
Tripodi A, Mannucci PM. The coagulopathy of chronic
liver disease. N Engl J Med. 2011;365(2):147-156. https://
doi.org/10.1056/nejmra1011170
Villanueva C, Colomo A, Bosch A, et al. Transfusion
strategies for acute upper gastrointestinal bleeding. N
Engl J Med. 2013;368(1):11-21. https://doi.org/10.1056/
nejmoa1211801
WOMAN Trial Collaborators. Effect of early tranexamic
acid administration on mortality, hysterectomy, and other
morbidities in women with post-partum haemorrhage
(WOMAN): an international, randomised, double-blind,
2116. https://doi.org/10.1016/s0140-6736(17)30638-4
Yank V, Tuohy CV, Logan AC, et al. Systematic
review: benefits and harms of in-hospital use of
recombinant factor VIIa for off-label indications.
org/10.7326/0003-4819-154-8-201104190-00004
Obstructive Shock
Angle MR, Molloy DW, Penner B, Jones D, Prewitt RM.
The cardiopulmonary and renal hemodynamic effects
of norepinephrine in canine pulmonary embolism.
Chest.
1989;95(6):1333-1337.
https://doi.org/10.1378/
chest.95.6.1333
Berg KM, Soar J, Andersen LW, et al. Adult advanced
life support: 2020 international consensus on cardiopul-
monary resuscitation and emergency cardiovascular care
science with treatment recommendations. Circulation.
2020;142(16_suppl_1):S92-S139. https://doi.org/10.1161/
cir.0000000000000893
Chatterjee S, Weinberg I, Yeh RW, et al. Risk factors
for intracranial haemorrhage in patients with pulmonary
embolism treated with thrombolytic therapy development
of the PE-CH score. Thromb Haemost. 2017;117(2):246-
251. https://doi.org/10.1160/th16-07-0588
Curtis GM, Lam SW, Reddy AJ, Bauer SR. Risk
factors associated with bleeding after alteplase admin-
istration for pulmonary embolism: a case-control study.
2014;34(8):818-825.
https://doi.
org/10.1002/phar.1440
Daley MJ, Lat I. Clinical controversies in thrombolytic
therapy for the management of acute pulmonary embo-
org/10.1002/phar.1051
Farmakis I, Cushman M, Valerio L, et al. Social
determinants of health and pulmonary embolism treat-
ment and mortality: the Nationwide Inpatient Sample.
Presented at: 64th American Society of Hematology
Annual Meeting and Exposition; December 10, 2022;
New Orleans, LA.
Greyson CR. Pathophysiology of right ventricular fail-
doi.org/10.1097/01.ccm.0000296265.52518.70
Hoeper MM, Granton J. Intensive care unit manage-
ment of patients with severe pulmonary hypertension
2011;184(10):1114-1124.
https://doi.org/10.1164/
rccm.201104-0662ci
Jaff MR, McMurtry MS, Archer SL, et al. Management
of massive and submassive pulmonary embolism,
iliofemoral deep vein thrombosis, and chronic throm-
boembolic
pulmonary
hypertension:
a
scientific
statement from the American Heart Association.